Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma
Claudio Anasetti(Moffitt Cancer Center), John A. Hansen(Bloodworks Northwest), Jean E. Sanders(Carolinas Medical Center), Paul J. Martin(Bloodworks Northwest), E. Donnall Thomas(AbbVie (United States)), Patrick G. Beatty(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R Storb(Fred Hutch Cancer Center), Motomi Mori(St. Jude Children's Research Hospital)
Cited by 345
Related Papers
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Antileukemic Effect of Chronic Graft-versus-Host Disease
|New England Journal of Medicine|1981|1.1k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848